Infinant Health Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$65M
- Investors
-
17
Infinant Health General Information
Description
Developer of the infant microbiome intended to support infant gut health. The company offers drugs through multiple clinical studies targeting various infant health conditions and diseases, and helps to prevent necrotizing enterocolitis, which is primarily seen in preterm infants and occurs when the intestinal wall lining becomes inflamed and dies, enabling healthcare professionals to support the healthy immune system function of infants.
Contact Information
Website
www.infinanthealth.comCorporate Office
- 2121 2nd Street
- Suite B107
- Davis, CA 95618
- United States
Corporate Office
- 2121 2nd Street
- Suite B107
- Davis, CA 95618
- United States
Infinant Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series D) | 25-May-2021 | $65M | Completed | Clinical Trials - General | ||
| 6. Debt - PPP | 11-Jun-2020 | Completed | Clinical Trials - General | |||
| 5. Later Stage VC (Series C) | 13-Jun-2018 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series B) | 30-May-2017 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC (Series A) | 17-Aug-2015 | Completed | Startup | |||
| 2. Seed Round | 15-Sep-2014 | $1M | $1M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Infinant Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D-2 | ||||||||
| Series D-1 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A | 2,091,709 | $0.000100 | $0.34 | $4.3 | $4.3 | 1x | $4.3 | 10.19% |
| Seed | 725,098 | $0.000100 | $0.11 | $1.32 | $1.32 | 1x | $1.32 | 3.53% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Infinant Health Comparisons
Industry
Financing
Details
Infinant Health Competitors (17)
One of Infinant Health’s 17 competitors is Persephone (Drug Discovery), a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Persephone (Drug Discovery) | Venture Capital-Backed | San Diego, CA | ||||
| Xeno Biosciences | Venture Capital-Backed | Cambridge, MA | ||||
| Infant Bacterial Therapeutics | Corporation | Stockholm, Sweden | ||||
| Rebiotix | Formerly VC-backed | Roseville, MN | ||||
| BiomX | Formerly VC-backed | Gaithersburg, MD |
Infinant Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Infinant Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Infinant Health Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cargill | Corporation | Minority | ||
| iSelect Fund | Venture Capital | Minority | ||
| Manna Tree Partners | PE/Buyout | Minority | ||
| Skyviews Life Science | Venture Capital | Minority | ||
| Spur Capital Partners | Fund of Funds | Minority |
Infinant Health FAQs
-
When was Infinant Health founded?
Infinant Health was founded in 2011.
-
Where is Infinant Health headquartered?
Infinant Health is headquartered in Davis, CA.
-
What is the size of Infinant Health?
Infinant Health has 7 total employees.
-
What industry is Infinant Health in?
Infinant Health’s primary industry is Drug Discovery.
-
Is Infinant Health a private or public company?
Infinant Health is a Private company.
-
What is the current valuation of Infinant Health?
The current valuation of Infinant Health is .
-
What is Infinant Health’s current revenue?
The current revenue for Infinant Health is .
-
How much funding has Infinant Health raised over time?
Infinant Health has raised $135M.
-
Who are Infinant Health’s investors?
Cargill, iSelect Fund, Manna Tree Partners, Skyviews Life Science, and Spur Capital Partners are 5 of 17 investors who have invested in Infinant Health.
-
Who are Infinant Health’s competitors?
Persephone (Drug Discovery), Xeno Biosciences, Infant Bacterial Therapeutics, Rebiotix, and BiomX are some of the 17 competitors of Infinant Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
